Related by context. All words. (Click for frequent words.) 66 Digital Mammographic Imaging 64 multicentre prospective 63 observational cohort 63 Renal Cell Carcinoma RCC 62 budesonide MMX Phase III 62 Screening Trial DMIST 62 CHAMPION PCI 62 BEXXAR Therapeutic Regimen 62 retrospective cohort 61 prospective longitudinal 61 number NCT# ClinicalTrials.gov 61 Proellex TM 61 REVIVE Diabetes 61 vaccinees 61 TAXUS ARRIVE 61 VTEUs 61 limiting generalizability 61 ARIXTRA R 61 Phase IIIB IV 61 FluCAM arm 61 Wisconsin Sleep Cohort 61 PREVENAR 60 Arch Intern Med 60 thorough QT 60 ICD therapy 60 Vaccine Immunology 60 relapsed MM 60 HF ACTION 60 BARI 2D 60 vismodegib 60 anagrelide 60 ACTEMRA TM 60 microbiologically evaluable 60 MERLIN TIMI 60 antipsychotic prescribing 60 LUMINATE 60 null responder 60 NINR 60 Zemplar Capsules 60 phase IIIb 60 postexposure prophylaxis 60 PCV# 60 Intervention Trial GAIT 60 reduce serum phosphate 60 Current Controlled Trials 60 Intravenous immunoglobulin 60 EchoCRT 60 psoriatic arthritis PsA 60 rALLy 60 rALLy trial 60 aldosterone antagonist 60 adult chronic ITP 59 7 valent pneumococcal 59 DF HCC 59 Twinrix 59 HealthGrades analyzed 59 oral FTY# 59 Hepatotoxicity 59 JHUSON 59 perinatal outcomes 59 RESOLUTE clinical 59 ONTARGET 59 CALGB # [002] 59 Influenza vaccination 59 baccalaureate nursing 59 GERD migraine headaches 59 RSV hospitalizations 59 CaPSURE 59 clinically evaluable 59 certolizumab 59 TYSABRI therapy 59 placebo controlled clinical 59 quadrivalent HPV vaccine 59 guideline concordant 59 ICAEL 59 antenatal corticosteroids 59 ACOSOG Z# 59 RN PhD FAAN 59 DAPT Study 59 prospectively enrolled 59 postmarketing adverse 59 CALGB 59 NATRECOR ® 59 confirmatory clinical 59 ACS NSQIP 59 ThermoDox ® clinical 59 Antibiotic resistant infections 59 GAMMAGARD 59 MenACWY CRM 59 RECORD1 59 relapsed ALL 59 MAGE A3 ASCI 59 herpes zoster vaccine 59 EDEMA3 59 VADT 59 clinicaltrials 59 treatment naive genotype 58 APEX AMI 58 prospective nonrandomized 58 journal Resuscitation 58 Hepatocellular Carcinoma HCC 58 ANN INTERN MED 58 Kathleen Dracup 58 CIMZIA TM certolizumab pegol 58 hyperphenylalaninemia HPA due 58 meta regression 58 clevidipine 58 Sociodemographic 58 please visit www.brighamandwomens.org 58 Arranon 58 Arch Surg 58 forodesine 58 morphometric vertebral fractures 58 prospective observational cohort 58 TYGACIL 58 tipranavir ritonavir 58 PARTNER Trial 58 IMPROVE HF 58 prospective observational studies 58 PPSV# 58 de novo AML 58 ARCOXIA 58 antiretroviral naïve 58 prospective multicentre 58 EMPHASIS HF trial 58 LAB CGRP 58 LibiGel Phase III 58 hepatitis B vaccination 58 randomized controlled trials RCTs 58 REVEAL Registry 58 ACNP 58 chlamydial infections 58 observational cohort study 58 HIV coinfected 58 bazedoxifene conjugated estrogens 58 journal CHEST 58 APEX AMI trial 58 cardiac perfusion 58 HIV HCV coinfected 58 methotrexate therapy 58 ROCKET AF 58 CATIE AD 58 visceral metastases 58 constipation OIC 58 multicenter trials 58 ClinicalTrials.gov 58 ExTRACT TIMI 58 clinical pharmacology studies 58 NSABP B 58 PhG alpha 1 58 kidney urologic 58 biologic DMARDs 58 Bayer HealthCare Onyx Pharmaceuticals 58 papillary renal cell carcinoma 58 rindopepimut 58 ROTARIX 58 GOUT 58 serogroup B 58 PROactive study 58 allogeneic HSCT 58 heFH 58 relapsing remitting MS RRMS 58 HBV infections 58 STRIDE PD 58 MGd 58 blinded randomized placebo controlled 58 TransVax ™ 58 HIB vaccine 58 REMINYL ® 58 infantile colic 58 subcutaneous immunoglobulin 58 phase IIb study 58 MMRV vaccine 58 recurrent glioblastoma multiforme 58 conducted retrospective cohort 58 varicella vaccination 58 azilsartan medoxomil 58 ZOLINZA 57 inhalation toxicology 57 serologic testing 57 untreated OSA 57 CoC accredited 57 peripartum 57 IPAH 57 MADIT 57 oral ridaforolimus 57 MYCAMINE 57 BRIM2 57 Intervention Effectiveness 57 ACRIN 57 DMIST 57 AIR CF1 57 ENDEAVOR III 57 Translational Science Award 57 OPT CHF 57 rheumatologic 57 riociguat 57 PERSEUS clinical program 57 Multicenter Automatic Defibrillator Implantation 57 Phase III ThermoDox 57 gynecologic procedures 57 lenalidomide Revlimid R 57 Carotid Revascularization Endarterectomy vs. 57 Common Toxicity Criteria 57 quinacrine 57 DVT PE 57 QOPI 57 clinical 57 hypersensitivity allergic reactions 57 extracolonic findings 57 diagnosing ADHD 57 NOMID 57 gastroenterological 57 glucocorticoid induced osteoporosis 57 cranial radiation 57 evaluating Actimmune 57 clinico pathological 57 OAB symptoms 57 endometriosis ovarian cysts 57 ZACTIMA 57 recurrent metastatic 57 4CMenB 57 PET CT scanning 57 NATRECOR R 57 HCV SPRINT 57 biologic DMARD 57 myelodysplastic myeloproliferative diseases 57 cytomegalovirus infection 57 TASKi2 57 pediatrics obstetrics 57 postmenopausal osteoporotic women 57 HORIZONS AMI trial 57 BEXXAR therapeutic regimen 57 CAPRIE 57 sargramostim 57 cystinosis patients 57 hepatitis B immune globulin 57 NSABP 57 Registered Nurse RN 57 bardoxolone methyl 57 podiatric medical 57 preclinical efficacy 57 EASE Program 57 Screening Trial 57 masitinib 57 NABTT 57 neurology cardiology 57 RRMS patients 57 midstage clinical 57 Oncotype 57 ZOSTAVAX 57 SCIg 57 diabetic neuropathic pain 57 NP2 Enkephalin 57 Vitaxin 57 topical NSAIDs 57 basal bolus regimen 57 preventing premature births 57 Multicenter AIDS 57 Edge STudy 57 LHON 57 pediatrics psychiatry 57 PLCO 57 influenzalike illness 57 venous thromboembolic disease 57 genitourinary cancers 57 amalgam fillings mercury vapor 57 dose escalation phase 57 NNT = 57 PFO migraine 57 metaanalysis 57 BR.# 57 aldosterone antagonists 57 OLYMPIA registry 57 Acute Decompensated Heart Failure 57 cardiology ophthalmology 57 Phase Ib clinical 57 ICD implants 57 ADVANCE PD 57 chemoprevention trials 57 OvaRex ® MAb 57 Dialysis Outcomes 57 PRECISE Trial 57 XL# SAR# 57 certified geriatricians 56 non adjuvanted vaccines 56 Abdominal ultrasound 56 didactic lectures 56 Phase 1a clinical 56 via intradermal injections 56 Clinicaltrials.gov 56 AIR2 Trial 56 journal Ambulatory Pediatrics 56 Perforomist ™ Inhalation Solution 56 NeuroStar TMS Therapy 56 toenail onychomycosis 56 Phase Ib IIa 56 pharmacologic stress 56 antiretroviral naive 56 laparoscopic bariatric surgery 56 ongoing Phase IIIb 56 tumor histology 56 Degarelix 56 APPRAISE 56 Randomized controlled 56 abnormal cytology 56 suboptimal adherence 56 cancer neurology ophthalmology 56 pediatric rheumatologists 56 Velcade bortezomib 56 Meta analyzes 56 CIMZIA ™ 56 inactivated influenza vaccine 56 visilizumab 56 undergoing peritoneal dialysis 56 late onset Pompe 56 oncology radiation oncology 56 antithrombotic therapy 56 iniparib BSI 56 including eniluracil ADH 56 Certified nurse midwives 56 Sudhir Agrawal D.Phil 56 metastatic gastric 56 ER CHOP 56 Tesmilifene 56 PSMA ADC 56 Acute Ischemic Stroke 56 Ophena TM 56 Physical Therapy Occupational Therapy 56 Primary endpoints 56 ENESTnd 56 gadobutrol 56 trastuzumab DM1 T DM1 56 Acute Coronary Syndromes ACS 56 radiologic technologists 56 ASPIRE HIGHER 56 underwent CABG 56 miRview ™ mets 56 MYTHOS trial 56 torcetrapib atorvastatin 56 ChronVac C R 56 CTSAs 56 atherothrombosis 56 HCV antibody 56 APEX PD 56 dirucotide MBP# 56 osteoporotic compression fractures 56 Decompensated Heart Failure 56 SNT MC# 56 BRIM3 56 evaluating mipomersen 56 metastatic neuroendocrine tumors 56 syndromic 56 Zenvia Phase III 56 SNT-MC#/idebenone 56 ASCEND HF 56 PANVAC VF 56 patients undergoing CABG 56 perinatal depression 56 ADMIRE HF 56 EMBLEM TM 56 antithrombotic therapies 56 Nurse midwives 56 NAMCS 56 velafermin 56 Evoltra ® 56 intradermal vaccine 56 GCP compliant 56 EBUS FNA 56 pain palliation 56 canakinumab 56 journal Epilepsia 56 lidocaine gel 56 thromboprophylaxis 56 pharmacologic treatments 56 PatientKeeper Charge Capture 56 retrospectively analyzed 56 tetanus diphtheria acellular pertussis 56 symptomatic VTE 56 ROTATEQ 56 placebo controlled clinical trials 56 attain statistical significance 56 Urocortin 2 56 AML MDS 56 HealthCore 56 SCD HeFT 56 vitamin D inadequacy 56 Alzheimer Disease Cooperative 56 CMV vaccine 56 thetreatment 56 teriflunomide 56 AVERROES 56 AIR CF2 56 randomized Phase IIb 56 Dr. Kandzari 56 Interview Survey CHIS 56 VTE prevention 56 ORENCIA R 56 localized prostate 56 NCCN guidelines 56 journal Menopause 56 Recurrent Glioblastoma 56 COR Analyzer 56 interventional cardiac 56 discontinued Viread 56 Phase IIIb clinical 56 Vascugel ® 56 Buerhaus 56 PREZISTA r arm 56 CARE HF 56 EURIDIS 56 PRIMO CABG 56 prospectively stratified 56 BRCA testing 56 PK PD modeling 56 Patient Registry 56 PERSEUS 56 ISEL 56 Nesiritide 56 Thorough QT 56 Canvaxin TM 56 null responder HCV 56 spontaneous regression 56 Nonclinical 56 physicians podiatrists 56 MRSA colonization 56 rALLy clinical trial 56 BCIRG 56 HORIZONS AMI 56 Pemphigus 56 histologically proven 56 SEISMIC Trial 56 ENDEAVOR IV 56 Pneumococcal pneumonia 56 Altastaph 56 Szeinbach 56 coronary revascularization procedures 56 SIMPADICO 56 hypereosinophilic syndrome 56 Inflammatory diseases 56 RSD# oral 56 TRA 2P 56 postdoctoral trainees 56 ColorectAlert TM 56 coagulation abnormalities 56 ACCORD Lipid 56 chronic HBV 56 Anna Taddio 56 dentistry optometry podiatry 56 Phenylketonuria PKU 56 YONDELIS 56 resectable pancreatic cancer 56 micafungin 56 KRAS mutations occur 56 ospemifene 56 dosing cohort 56 acellular pertussis DTaP 56 atherothrombotic disease 56 James Cerhan MD 56 Dr. Fehlings 56 TMS Therapy 56 HGS# 56 AA Amyloidosis 56 CIPN 56 cervical precancerous lesions 56 HeFH 56 longitudinal cohort study 56 Teplizumab 56 ONCONASE R 56 retrospective cohort study 56 Allovectin 7 ® 56 Fabry Disease 56 galiximab 56 LC#m# vaccine 56 CINQUIL 56 management biostatistical analysis 56 fosbretabulin 56 p# biomarker 56 antiepileptics 56 intravenous RSD# 56 #:#-#,# CrossRef Medline [002] 56 pacemaker manufacturer Intrapace 56 intradermal injections 56 smoldering myeloma 56 recurrent malignant glioma 56 bepotastine besilate nasal spray 56 Coronary CTA 56 AMEVIVE 56 aripiprazole Abilify 56 Translational Science Awards 56 cardio renal 56 interstitial brachytherapy 56 demonstrated clinically meaningful 56 ß blockers 56 CERVARIX 55 samalizumab 55 nutrient supplementation 55 gastrointestinal malignancies 55 PASI scores 55 fetal malformations 55 Eric Boerwinkle 55 Pharmacoeconomic 55 Group RTOG 55 antiarrhythmic drug 55 Diamyd r 55 rFSH 55 recurrent glioma 55 Tobinick 55 definite stent thrombosis 55 TAXUS IV 55 lipid lowering agents 55 Early Childhood Longitudinal Study 55 Dr. Assa Amit 55 MediGene focuses 55 commercialize deforolimus 55 CYT# potent vascular disrupting 55 Teriflunomide 55 prospective multicenter study 55 Triapine R 55 migraine prophylaxis 55 trials RCTs 55 ALGRX 55 RELOVAIR ™ 55 unresectable tumors 55 GRN# 55 NCT# ClinicalTrials.gov 55 Vitrea ® 55 defibrillator implantation 55 MIST II 55 retrospective observational study 55 preterm newborns 55 AIM HIGH 55 CPAP adherence 55 efalizumab 55 phase IIa clinical 55 nadroparin 55 HCD# [002] 55 Rheumatologists 55 pharmacokinetic PK study 55 oral talactoferrin 55 DAPT 55 Cervical Cytology 55 OHRI 55 ACR# ACR# 55 Aryplase 55 IMPACT DCM 55 PLX STROKE targeting 55 dermatologic disorders 55 ENDEAVOR clinical 55 ABSORB trial 55 QTinno 55 IOP lowering 55 ACLS certification 55 TNFerade TM 55 overt nephropathy 55 CYPHER Stent 55 HER2 expression 55 endocrinology gastroenterology 55 blinded randomized controlled 55 Chronic Heart Failure 55 TQT 55 LEUKINE 55 invasive aspergillosis 55 epidemiology biostatistics 55 reslizumab 55 transcatheter aortic valve implantation 55 congenital toxoplasmosis 55 preclinical pharmacokinetic 55 abnormal Pap smear 55 MenACWY 55 Long Lesion 55 clinicaltrials.gov 55 retrospective observational 55 non CF bronchiectasis 55 Avastin adjuvant 55 Clinical Antipsychotic Trials 55 alvespimycin 55 uncomplicated influenza 55 Pneumonia vaccine 55 VTE prophylaxis 55 PROCHYMAL 55 underwent resection 55 PEARL SC 55 comorbid ADHD 55 MTWA testing 55 Arch Neurol 55 GBA mutations 55 antiplatelet medications 55 preadmission 55 ToGA 55 Xelox 55 Voraxaze ™ 55 HPTN 55 GI motility disorders 55 bronchogenic carcinoma 55 metastatic lung cancer 55 candidemia 55 phase Ib 55 genotypic resistance 55 arterial thromboembolic events 55 NO# [002] 55 NPWH 55 CAAHEP 55 Deutsches Arzteblatt International 55 MEDMARX 55 THALOMID 55 GPRD 55 pediatric nurse practitioners 55 Cervical Pathology 55 LHRH receptor positive 55 PLoS ONE journal 55 dacarbazine chemotherapy 55 practitioners internists 55 patientswith 55 underwent coronary angiography 55 cervical dysplasia 55 autism spectrum diagnoses 55 Neuroepidemiology 55 severe exacerbations 55 relapsed MCL 55 paclitaxel eluting stents 55 Pediatric Diabetes 55 BOLDER II 55 Phase III HEAT 55 deCODE AF TM 55 EMPHASIS HF 55 SEER database 55 Hakon Hakonarson 55 Gerontologist 55 bicifadine 55 FROVA 55 NLSY 55 elective PCI 55 http:/www.clinicaltrials.gov 55 Relapsing remitting MS 55 CMV reactivation 55 microplasmin Phase III 55 radiologic sciences 55 Secondary efficacy endpoints 55 recurrent herpes labialis 55 surfactant therapy 55 hematological malignancy 55 myocardial infarctions MIs 55 EXPLORE Xa 55 BARACLUDE ® 55 confirmatory Phase IIIb 55 PRESEPT study 55 placebo controlled Phase III 55 intracranial stenosis 55 AGGRASTAT ® tirofiban hydrochloride 55 CELVAPAN H#N# 55 ENDEAVOR II 55 CIBMTR 55 CLBP 55 John R. Plachetka 55 deep venous thromboses 55 Golimumab 55 sunitinib malate 55 VNACJ 55 interprofessional education 55 NYP-NEWS 55 noncardiac chest pain 55 Non inferiority 55 Guillermo Torre Amione 55 Systemic Lupus Erythematosus SLE 55 pharmacogenetic testing 55 oral prednisolone 55 Subgroup analyzes 55 pharmacologic therapies 55 chorioamnionitis 55 venlafaxine Effexor 55 Prostate AdenoCarcinoma Treatment 55 inhaled tobramycin 55 WGU nursing 55 abstracts summarizing 55 BRCA mutation carriers 55 EOquin TM phase 55 assn.org 55 senicapoc 55 Cimzia TM 55 Prodarsan R 55 OSAHS 55 ticagrelor Brilinta 55 randomized multicenter trial 55 C. diff infections 55 severe hypercholesterolemia 55 Hepatitis C Antiviral 55 LV dysfunction 55 nucleoside naive patients 55 allergen avoidance 55 trivalent inactivated influenza 55 bone density measurements 55 nonmelanoma skin cancers 55 mild hepatic impairment 55 Novartis MenB vaccine 55 immunodeficiencies 55 ALTROPANE 55 Services #:#-#,# Abstract 55 eTag assays 55 LungSign TM 55 VTEU 55 multicenter Phase III 55 conjugate pneumococcal vaccine 55 arboviral 55 thrombocytopenic 55 ofpatients 55 NREMT 55 NICE guideline 55 Pneumococcal vaccines 55 evaluable subjects 55 osteoarthritic pain 55 cat dander allergy 55 Gamunex C 55 VESTASYNC II trial 55 inhospital 55 Health Initiative Observational 55 placebo controlled multicenter 55 GnRH agonists 55 PORxin TM platforms 55 Myelodysplastic syndromes MDS 55 atrial fibrillation ablation 55 Lung transplantation 55 Lysteda 55 non squamous NSCLC 55 Ambulatory Pediatrics 54 eMR 54 tamoxifen Nolvadex ® 54 fostamatinib 54 noscapine 54 Phase Ib II 54 pediatrics geriatrics 54 OHSU Doernbecher 54 WHIMS 54 hepatitis C genotype 54 CTAP# Capsules 54 NSQIP 54 haematologic 54 stratifying patients 54 rheumatoid arthritis osteoarthritis ankylosing 54 EDEMA3 trial 54 pyridostigmine 54 GeoVax vaccine 54 ALSYMPCA 54 nucleoside naive 54 corticosteroid dose 54 Spectranetics laser 54 oral methylnaltrexone 54 ASPS statistics 54 NHAMCS 54 Reefhuis 54 Heavy menstrual bleeding 54 Dacogen injection 54 novel VDA molecule 54 CONQUER OB 54 CRLX# 54 neurosensory 54 Engerix B 54 postoperative chemotherapy 54 epoetin alpha 54 ragweed allergic 54 Manja Bouman CEO 54 Certified Nurse Midwives 54 neurology gastroenterology 54 simplex virus 54 randomizing patients 54 Unstable Angina 54 Women Ischemia Syndrome 54 TBC# 54 mSEPT9 biomarker 54 DLQI 54 BENICAR HCT 54 MAGE A3 protein 54 virus HBV 54 ACUITY trial 54 subthreshold depression 54 randomized controlled multicenter 54 Phase 2a preventative 54 DXA scan 54 dyslipidemia hypertension diabetes 54 MDRF 54 ONCOLOGY 54 Cloretazine 54 intravenous bisphosphonates 54 symptomatic DVT 54 ABSSSI 54 multicenter Phase 54 TAXUS VI 54 phase IIa 54 Tectin TM 54 AVADO 54 myocardial infarction ventricular fibrillation 54 antioxidant supplementation 54 QualityMetric 54 www.med.umich.edu 54 Venous thromboembolism 54 Estybon ™ 54 HuMax EGFr 54 Daclizumab 54 HYVET 54 oxycodone CR 54 SWiTCH 54 Afatinib 54 ICON7 54 Fibrillex TM 54 INTERCEPT platelets 54 pegylated interferon alfa 2b 54 hepatitis B immunization 54 ductal carcinomas 54 diagnosed glioblastoma 54 AGILECT R 54 intravesical infusion therapy 54 Option IVC Filter 54 systemic RNAi therapeutic 54 COU AA 54 histological subtype 54 therapists dieticians 54 USUHS 54 obstetric gynecologic 54 Raptiva ® 54 GeoVax HIV AIDS 54 GWTG CAD 54 Versant RN Residency 54 AFRS TM 54 FFR measurements 54 renal flares 54 NeuroFlo 54 tele ICU 54 COMFORT II 54 Aflibercept 54 Oncotype DX colon cancer 54 Inhaled nitric oxide 54 treating uterine fibroids 54 BPharm 54 PREGNANT Study 54 Nephrology Dialysis Transplantation 54 HER2 overexpression 54 Pivotal Phase III 54 pediatric acute lymphoblastic 54 intermittent dosing 54 dose Iluvien 54 Eli Lilly Cymbalta 54 CT perfusion 54 budesonide foam 54 BoNTA 54 journal Ophthalmology 54 CA9 SCAN 54 AACN 54 longitudinal cohort 54 Pap smear screening 54 APTIVUS 54 CMV infection 54 sonographic diagnosis 54 Trofex 54 DEB# 54 TG MV 54 RISPERDAL ® 54 bosutinib 54 mean ± SEM 54 APTIVUS ritonavir 54 targeting miR 54 BACcel 54 Respiratory Therapists 54 paclitaxel Taxol R 54 trivalent seasonal influenza 54 follicular lymphomas 54 carotid artery narrowing 54 cannabinor 54 occupational therapy physiotherapy 54 dose cohort 54 denosumab oncology clinical trials 54 Traficet EN 54 Colorectal cancer screening 54 ALI ARDS 54 Evelyn Intondi Planned Parenthood 54 Zestra R 54 postapproval 54 HCV RESPOND 2 54 oncologists radiation oncologists 54 pretreatment serum 54 Pentacel vaccine 54 candidate CRLX# 54 Diabetes Interventions 54 membranous nephritis 54 REALITY Trial 54 dose intramuscular 54 Prostate Cancer Prevention 54 DeKosky 54 decompensated liver disease 54 journal Anesthesia 54 thoracoscopic lobectomy 54 refractory metastatic 54 postdischarge 54 atherosclerotic renal artery stenosis 54 COBRE 54 postintervention 54 neuroradiologists 54 Chicago Multidisciplinary Symposium 54 orofacial clefts 54 recombinant PSMA vaccine 54 Menactra vaccine 54 inhaled corticosteroid therapy 54 urinary incontinence UI 54 antibiotic regimens 54 beta carotene supplementation 54 zoster vaccine 54 squamous cell lung cancer 54 ARIXTRA 54 Gynecological Cancer 54 invasive candidiasis 54 hemodynamic measurements 54 solifenacin 54 EECP therapy 54 Clinical Psychopharmacology 54 CCR5 receptor antagonist 54 brivaracetam 54 ertapenem 54 cerebral oximetry 54 abacavir Ziagen 54 J Rheumatol 54 postoperative pulmonary 54 tarenflurbil 54 oncologic outcomes 54 ELBW infants 54 asymptomatic PAD 54 #-# Full Text 54 Edward Giovannucci 54 vidofludimus 54 CompuFlo 54 Stenting Trial CREST 54 MACUGEN 54 angiographic outcomes 54 PEARL HF 54 prospectively defined 54 StemEx R 54 cesarean section births 54 MD MHSc 54 elotuzumab 54 theAmerican Journal 54 EmbraceAC 54 mailed questionnaires 54 Coronary Artery Bypass Graft 54 APTIVUS r 54 Phase IIIb study 54 attending antenatal clinics 54 BioSante LibiGel Phase III 54 Q#IR 54 eculizumab therapy 54 Liprotamase 54 viral kinetic 54 Val HeFT 54 perfusion CT 54 J Clin Oncol 54 prenatally diagnosed 54 S. aureus isolates 54 Tumor Registry 54 neoadjuvant treatment 54 R roscovitine 54 MADIT II 54 PREVU x LT 54 Temsirolimus 54 Cesarean deliveries 54 JACC Cardiovascular Interventions 54 pharmacogenetic tests 54 meningococcal conjugate vaccine 54 NAbs 54 oxymorphone ER 54 postexposure 54 Am J Geriatr 54 HBeAg negative 54 torezolid phosphate 54 alemtuzumab treated 54 MEND CABG 54 RE LY ® 54 antimicrobial prophylaxis 54 MYDICAR 54 multicenter randomized controlled 54 Uterine Fibroid 54 RSV infections 54 psychiatric comorbidities 54 laparoscopic partial nephrectomy 54 Zometa zoledronic acid 54 careHPV 54 optometry podiatry 54 Kiang Liu 54 ACGME accredited 54 endoscopists 54 Fluzone Intradermal vaccine 54 #:#-#,# CrossRef Medline [001] 54 Hematologic 54 CAMPATH 54 evaluating Nexavar 54 Pandemic Influenza H#N# 54 BioNumerik 54 Erimos 54 T1DM 54 apremilast 54 sextuplet births 54 orally inhaled migraine 54 CMV seropositive